Timing of pivotal clinical trial results reporting for newly approved medications varied by reporting source

Journal of Clinical Epidemiology

Volumn 77, Issue , 2016, Pages 78-83

  Withycombe, Bethany ^a   Ovenell, Mac ^a   Meeker, Amanda ^a   Ahmed, Sharia M ^a   Hartung, Daniel M ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Clinical trial registries; Clinical trial reporting; Unpublished evidence; US Food and Drug administration

Indexed keywords

NEW DRUG;

ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); DRUG APPROVAL; FOOD AND DRUG ADMINISTRATION; HUMAN; INTERNET; PRIORITY JOURNAL; PUBLICATION; TREATMENT OUTCOME; UNITED STATES; FACTUAL DATABASE; METHODOLOGY; PROCEDURES; STATISTICS AND NUMERICAL DATA; TIME;

CLINICAL TRIALS AS TOPIC; DATABASES, FACTUAL; DRUG APPROVAL; HUMANS; PUBLICATIONS; RESEARCH DESIGN; TIME; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84994504591     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2016.04.007     Document Type: Article

References (22)

1. [1] Goldberg, N.H., Schneeweiss, S., Kowal, M.K., Gagne, J.J., Availability of comparative efficacy data at the time of drug approval in the United States. JAMA 305 (2011), 1786–1789.
2. [2] Downing, N.S., Aminawung, J.A., Shah, N.D., Krumholz, H.M., Ross, J.S., Clinical trial evidence supporting FDA approval of novel therapeutic agents, 2005-2012. JAMA 311 (2014), 368–377.
3. [3] Services USDoHaH. Guidance for Industry: Providing Clinical Evidence of Effectiveness for Human Drug and Biological Products, 1998, Food and Drug Administration, Rockville, MD.
4. [4] Lee, K., Bacchetti, P., Sim, I., Publication of clinical trials supporting successful new drug applications: a literature analysis. PLoS Med, 5, 2008, e191.
5. [5] Smithy, J.W., Downing, N.S., Ross, J.S., Publication of pivotal efficacy trials for novel therapeutic agents approved between 2005 and 2011: a cross-sectional study. JAMA Intern Med 174 (2014), 1518–1520.
6. [6] Turner, E.H., How to access and process FDA drug approval packages for use in research. BMJ, 347, 2013, f5992.
7. [7] Chan, A-W., Out of sight but not out of mind: how to search for unpublished clinical trial evidence. BMJ, 344, 2012, d8013.
8. [8] Zarin, D.A., Tse, T., Williams, R.J., Califf, R.M., Ide, N.C., The ClinicalTrials.gov results database—update and key issues. New Engl J Med 364 (2011), 852–860.
9. [9] Zarin, D.A., Tse, T., Moving toward transparency of clinical trials. Science 319 (2008), 1340–1342.
10. [10] Zarin, D.A., Tse, T., Sheehan, J., The Proposed Rule for U.S. Clinical trial registration and results submission. New Engl J Med 372 (2015), 174–180.
11. [11] Prayle, A.P., Hurley, M.N., Smyth, A.R., Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: cross sectional study. BMJ, 344, 2012, d7373.
12. [12] Law, M.R., Kawasumi, Y., Morgan, S.G., Despite law, fewer than one in eight completed studies of drugs and biologics are reported on time on ClinicalTrials.gov. Health Aff (Millwood) 30 (2011), 2338–2345.
13. [13] Anderson, M.L., Chiswell, K., Peterson, E.D., Tasneem, A., Topping, J., Califf, R.M., Compliance with results reporting at ClinicalTrials.gov. New Engl J Med 372 (2015), 1031–1039.
14. [14] Nieves, J., Stack, K.M., Harrison, M.E., Gorman, J.M., Dysphagia: a rare form of dyskinesia?. J Psychiatr Pract 13 (2007), 199–201.
15. [15] Hartung, D.M., Zarin, D.A., Guise, J.M., McDonagh, M., Paynter, R., Helfand, M., Reporting discrepancies between the ClinicalTrials.gov results database and Peer-Reviewed publications. Ann Intern Med 160 (2014), 477–483.
16. [16] Song, F., Parekh, S., Hooper, L., Loke, Y.K., Ryder, J., Sutton, A.J., et al. Dissemination and publication of research findings: an updated review of related biases. Health Technol Assess (Winchester, England), 14, 2010, iii ix-xi, 1–193.
17. [17] Ross, J.S., Mulvey, G.K., Hines, E.M., Nissen, S.E., Krumholz, H.M., Trial publication after registration in ClinicalTrials.gov: a cross-sectional analysis. PLoS Med, 6, 2009, e1000144.
18. [18] Ross, J.S., Tse, T., Zarin, D.A., Xu, H., Zhou, L., Krumholz, H.M., Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis. BMJ, 344, 2012, d7292.
19. [19] Rising, K., Bacchetti, P., Bero, L., Reporting bias in drug trials submitted to the Food and drug administration: review of publication and presentation. PLoS Med, 5, 2008, e217.
20. [20] Tse, T., Williams, R.J., Zarin, D.A., Reporting “basic results” in ClinicalTrials.gov. Chest 136 (2009), 295–303.
21. [21] Becker, J.E., Krumholz, H.M., Ben-Josef, G., Ross, J.S., Reporting of results in ClinicalTrials.gov and high-impact journals. JAMA 311 (2014), 1063–1065.
22. [22] McDonagh, M.S., Peterson, K., Balshem, H., Helfand, M., US Food and Drug Administration documents can provide unpublished evidence relevant to systematic reviews. J Clin Epidemiol 66 (2013), 1071–1081.